Copper-catalyzed guanidinylation of aryl iodides: The formation of N,N′-disubstituted guanidines

Organic Letters

Volumn 12, Issue 6, 2010, Pages 1316-1319

  Cortes Salva, Michelle ^a   Nguyen, Be Lan ^a   Cuevas, Javier ^b   Pennypacker, Keith R ^b   Antilla, Jon C ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; GUANIDINE DERIVATIVE; IODINATED HYDROCARBON;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; STEREOISOMERISM; SYNTHESIS;

CATALYSIS; COPPER; GUANIDINES; HYDROCARBONS, IODINATED; MOLECULAR STRUCTURE; STEREOISOMERISM;

EID: 77949846399     PISSN: 15237060     EISSN: 15237052     Source Type: Journal    
DOI: 10.1021/ol1002175     Document Type: Article

References (35)

1. (a) De Deyn, P. P.; Marescau, B.; Quereshi, I. A.; Mori, A. In Guanidino Compounds in Biology and Medicine; John Libbey and Co.: London, 1997; Vol.2.
2. (b) Rodriguez, R.; Rozas, I.; Kaiser, M.; Bran, R.; Nguyen, B.; Wilson, W. D.; Garcia, R. N.; Dardonville, C. J. Med. Chem. 2008, 51, 909.
3. (c) Keller, M.; Pop, N.; Beck-Sickingger, A.; Bernhardt, G.; Buschauer, A. J. Med. Chem. 2008, 51, 8168.
4. (d) Gee, K. R.; Durant, G.; Holmes, D.; Magar, S. S.; Weber, E.; Wong, S. T.; Keana, J. F. W. Bioconjugate Chem. 1993, 4, 226.
5. (e) Evindar, G; Batey, R. A. Ore. Lett. 2003, 5, 133.
6. (f) Powell, D.; Batey, R. A. Ore. Lett. 2002, 4, 2913.
7. Ajmo, C. T., Jr.; Vernon, D. O.; Collier, L.; Pennypacker, K. R.; Cuevas, J. Curr. Neurousac. Res. 2006, 3, 89.
8. (a) Albers, G. W.; Amarenco, P.; Easton, J. D.; Sacco, R. L. Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004, 126, 483.
9. (b) Astrup, J.; Syrrion, L.; Branston, N. M.; Lassen, N. A. Stroke 1997, 8, 51.
10. (c) For pharmacology review, see: Su, T- P.; Maurice, T. Pharmacol. Ther 2009, 124, 195.
11. (a) Zhang, H.; Cuevas, J. J. Neurophysiol. 2002, 87, 2867.
12. (b) Zhang, H.; Cuevas, J. J. Pharmacol. Exp. Ther. 2005, 313, 1387.
13. (c) Waldmann, R.; Champigny, G.; Bassilana, F.; Heurteaux, C.; Lazdunski, M. Nature 1997, 386, 173.
14. (d) Katnik, C.; Guerrero, W. R.; Pennypacker, K. R.; Herrera, Y.; Cuevas, J. J. Pharmacol. Exp. Ther. 2006, 319 (3), 1355.
15. (a) Herrera, Y.; Katnik, C.; Rodriguez, J. R.; Hall, A. A.; Willing, A.; Pennypacker, K. Cuevas. J. J. Pharmacol. EXP. Ther. 2008, 327, 492.
16. (b) Xiong, Z. G.; Zhu, X. M.; Chu, X. P.; Minami, M.; Hey, J. Cell 2004, 118, 687.
17. Weber, E.; Sonder, M.; Quarum, M.; McLean, S.; Pou, S.; Keana, J. F. W. Proc Natl. Acad. Sci. U.S.A. 1986, 83, 8784.
18. (a) Bergfeld, M. et al. U.S. Patent 4, 898, 978, 1990.
19. (b) For a review on guanidine methods, see: Katritzy, A.; Rogovoy, B. V. Arkivoc 2005, iv, 49.
20. (c) Powell, D. A.; Ramsden, P. D.; Batey, R. A. J. Org. Chem. 2003, 68, 2300.
21. (d) Powell, D. A.; Batey, R. A. Chem. Commun. 2001, 2362.
22. (a) Uilmann, F. Ber. Dtsch. Chem. Ges. 1903, 36, 2382.
23. (b) Ma, D.; Zhang, Y.; Yao, J.; Wu, S.; Tao, F. J. Am. Chem. Soc. 1998, 120, 12459.
24. (c) Fagan, P. J.; Hauptman, E.; Shapiro, R.; Casalnuovo, A. Am. Chem. Soc. 2000, 122, 5043.
25. (d) Lang, F.; Zewge, D.; Houpis, I.; Volante, R. P. Tetrahedron Lett. 2001, 42, 3251.
26. Goldberg, I. Ber. Dtsch. Ges. 1906, 39, 1691.
27. (a) Tundel, R. E.; Anderson, K. W.; Buchwald, S. L. J. Org. Chem. 2006, 71, 430.
28. (b) Quach, T. D.; Batey, R. A. Org. Lett. 2003, 5, 4397.
29. (a) Shafir, A.; Buchwald, S. I, J. Am. Chem. Soc. 2006, 128, 8742.
30. (b) Antilla, J. C.; Baskin, J. M.; Barder, T.; Buchwald, S. L. J. Org. Chem. 2004, 69, 5578.
31. (d) Klapars, A.; Artilla, J. C.; Huang, X.; Buchwald, S. L. J. Am. Chem. Soc 2001, 123, 7723.
32. (a) Kwong, F. Y.; Klapars, A.; Buchwald, S. L. Org. Lett. 2002, 4, 581.
33. (b) Kwong, F. Y.; Buchwald, S. L. Org. Lett. 2003, 5, 793.
34. Deng, X.; McAllister, H.; Mani, N. S. J. Org. Chem. 2009, 74, 5742.
35. Cortes-Salva, M.; Behensky, A.; Ajino, C.; Pennypacker, K.; Cuevas, J.; Artilla, J. Design, synthesis and evaluation of guanidine analogs as potential drugs for stroke therapeutics; Presented at the 237th American Chemical Society National Meeting, March, 2009, Salt Lake City, UT; no.1216243.